Corcept Therapeutics | CORT - Loan Capital



Corcept Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.


Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Alaunos Therapeutics USD 0 0 Dec/2024
ANI Pharmaceuticals USD 608.35M 3.28M Jun/2025
Ardelyx USD 229.21M 78.36M Jun/2025
Aurora Cannabis CAD 36.3M 3.89M Jun/2025
BioMarin Pharmaceutical USD 596.16M 512K Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Canopy Growth CAD 289M 178.93M Jun/2025
Corcept Therapeutics USD 0 0 Mar/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
J&J USD 38.36B 7.7B Mar/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Merck USD 33.97B 484M Jun/2025
Novartis USD 24.06B 2.4B Jun/2025
Novartis USD 24.06B 1.13B Jun/2025
Pacira USD 378.1M 3.2M Jun/2025
Pfizer USD 57.5B 137M Jun/2025
Supernus Pharmaceuticals USD 0 0 Dec/2024
TG Therapeutics USD 245.04M 608K Jun/2025